Hello and welcome to The Kable for the last time this week for a surprisingly full read for a Friday. Well, at least you won't have to figure out your weekend reading.
The US FDA has come down with a heavy hand on manufacturing sites in the US too. Hikma Injectables' facility in Dayton, New Jersey received a Form 483 with three observations on quality la…